Nova Eye Medical Limited (ASX:EYE)
Australia
· Delayed Price · Currency is AUD 0.147
+0.002 (1.38%)
Mar 10, 2026, 11:20 AM AEST
Nova Eye Medical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -7.03 | -9.06 | -8.79 | -15.29 | -7.5 | -4.36 | Upgrade
|
| Depreciation & Amortization | 2.26 | 2.26 | 2.99 | 2.3 | 1.81 | 1.52 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 6.04 | - | - | Upgrade
|
| Stock-Based Compensation | 0.09 | 0.09 | 0.04 | 0.18 | 0.2 | - | Upgrade
|
| Other Operating Activities | 0.34 | 1.09 | -0.13 | -0.24 | -1.63 | -0.18 | Upgrade
|
| Change in Accounts Receivable | -0.1 | -0.1 | -1.86 | -0 | 1.82 | -1.62 | Upgrade
|
| Change in Inventory | 0.29 | 0.29 | -0.48 | -0.27 | -0.64 | 0.03 | Upgrade
|
| Change in Accounts Payable | -1.22 | -1.22 | -0.8 | 0.53 | 0.54 | -1.82 | Upgrade
|
| Change in Income Taxes | - | - | 0.88 | 0.69 | -0.16 | -8.15 | Upgrade
|
| Change in Other Net Operating Assets | 0.5 | 0.5 | 0.28 | 0.21 | 0.01 | 1.43 | Upgrade
|
| Operating Cash Flow | -4.87 | -6.15 | -7.86 | -6.82 | -4.72 | -13.14 | Upgrade
|
| Capital Expenditures | -0.34 | -0.3 | -0.21 | -0.26 | -0.13 | -0.38 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -0.99 | Upgrade
|
| Divestitures | - | - | - | - | 2.02 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.14 | -0.15 | -0.24 | -0.54 | -5.46 | -1.85 | Upgrade
|
| Other Investing Activities | 0.07 | 0.09 | 0.12 | 0.1 | -0.97 | 0.24 | Upgrade
|
| Investing Cash Flow | -0.41 | -0.36 | -0.33 | -0.7 | -4.54 | -2.98 | Upgrade
|
| Long-Term Debt Repaid | - | -0.61 | -0.52 | -0.65 | -0.4 | -0.58 | Upgrade
|
| Net Debt Issued (Repaid) | -0.65 | -0.61 | -0.52 | -0.65 | -0.4 | -0.58 | Upgrade
|
| Issuance of Common Stock | 6.17 | 6.17 | 7.43 | 7.47 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -41.64 | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -19.39 | Upgrade
|
| Financing Cash Flow | 5.52 | 5.56 | 6.91 | 6.82 | -0.4 | -61.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.12 | -0.14 | 0 | 0.12 | -0.14 | -0.11 | Upgrade
|
| Net Cash Flow | 0.37 | -1.1 | -1.27 | -0.58 | -9.8 | -77.85 | Upgrade
|
| Free Cash Flow | -5.21 | -6.45 | -8.07 | -7.09 | -4.85 | -13.53 | Upgrade
|
| Free Cash Flow Margin | -15.77% | -22.03% | -34.59% | -41.63% | -36.27% | -100.99% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 | -0.09 | Upgrade
|
| Cash Interest Paid | 0.16 | 0.16 | 0.06 | 0.05 | 0.06 | 0.07 | Upgrade
|
| Cash Income Tax Paid | - | - | -0.88 | -1.4 | -1.42 | 8.85 | Upgrade
|
| Levered Free Cash Flow | -2.68 | -3.17 | -4.92 | -3 | -8.17 | -14.83 | Upgrade
|
| Unlevered Free Cash Flow | -2.57 | -3.07 | -4.88 | -2.96 | -8.13 | -14.79 | Upgrade
|
| Change in Working Capital | -0.53 | -0.53 | -1.97 | 0.19 | 2.39 | -10.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.